Literature DB >> 25820053

Iatrogenic mitral stenosis following transcatheter aortic valve replacement (TAVR).

Iwan Harries1, Badrinathan Chandrasekaran1, Edward Barnes1, Steve Ramcharitar2.   

Abstract

A 57 year old female underwent transcatheter aortic valve replacement (TAVR) for severe aortic stenosis. Mild iatrogenic mitral stenosis was noted intraoperatively. Attempts to reposition the device were hampered by aortic angulation. One year later, severe mitral stenosis was confirmed on transoesophageal echocardiography. It is important to recognise that iatorgenic mitral stenosis due to TAVR may progress over time. Care should be taken to minimise the risk of this rare complication.
Copyright © 2015 Cardiological Society of India. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25820053      PMCID: PMC4382556          DOI: 10.1016/j.ihj.2015.02.005

Source DB:  PubMed          Journal:  Indian Heart J        ISSN: 0019-4832


  2 in total

1.  Acute mitral stenosis after transcatheter aortic valve implantation.

Authors:  Eduardo Franco; José Alberto de Agustín; Rosana Hernandez-Antolin; Eulogio Garcia; Jacobo Silva; Luis Maroto; Carmen Olmos; Elena Fortuny; Dafne Viliani; Carlos Macaya; Jose Zamorano
Journal:  J Am Coll Cardiol       Date:  2012-11-13       Impact factor: 24.094

2.  Transcatheter Aortic Valve Implantation (core valve) prosthesis complicated by mitral stenosis.

Authors:  Mohammed Balghith; Ahmad Omran; Ahmad Saileek; Ali Alghamdi; Hani Najm
Journal:  J Saudi Heart Assoc       Date:  2012-03-07
  2 in total
  1 in total

1.  Previous TAVR in patients undergoing percutaneous edge-to-edge mitral valve repair (PMVR) affects improvement of MR.

Authors:  Johannes Patzelt; Miriam Ulrich; Annika Becker; Karin A L Müller; Rezo Jorbenadze; Michal Droppa; Wenzhong Zhang; Sarah Mandel; Lisa Habel; Henning Lausberg; Janine Pöss; Tobias Geisler; Oliver Borst; Peter Rosenberger; Christian Schlensak; Meinrad Gawaz; Jürgen Schreieck; Peter Seizer; Harald F Langer
Journal:  PLoS One       Date:  2018-10-19       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.